NCT06505564
VR-based Avatar Therapy for Treatment of Auditory Hallucinations
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 16 words
- Trial status changed: Unknown → Completed
- Secondary endpoints: details revised at 6 of 6 entries
- Site details revised at 4 of 4 sites
- Minor Changed Registry marked status Unknown; last known: Recruiting
- Minor Trial status: Recruiting to Unknown
- Secondary endpoints: details revised at 6 of 6 entries
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Change in symptom severity
Timeframe: Week 0, Week 12, Week 24
Change in severity of auditory hallucinations
Timeframe: Week 0, Week 12, Week 24
Change in beliefs about voices in schizophrenia spectrum disorder
Timeframe: Week 0, Week 12, Week 24
Secondary (6)
Change in comorbidity (depression)
Change in comorbidity (anxiety)
Change in health-related quailty of life
Change in subjective well-being
Change in emotion regulation
Show 1 moreShow less
Change in self-efficacy
Arms and interventions
AVATAR therapyExperimental
All participants will initially undergo a 12-week waiting period (control period) starting from the initial screening at week 0. Baseline assessments will be conducted at week 12. Subsequently, participants will receive AVATAR therapy for 12 weeks. Post-therapy assessments will be conducted at week 24. Caregivers and therapists will also provide evaluations to gather additional insights into the therapy's impact
Behavioral: AVATAR therapy
Sites
4 sites in 3 countries
Spain 2, Hungary 1, Poland 1